Article

Pilot study: Papillary thickness in optic nerve head edema

A spectral-domain optical coherence tomography (SD-OCT) star-pattern scan (SPS) acquisition protocol may be a more accurate and sensitive baseline measure for the diagnosis and follow-up of papilledema than presently used methods, according to the results of a pilot study, said Mazen Y. Choulakian, MD.

Fort Lauderdale, FL-A spectral-domain optical coherence tomography (SD-OCT) star-pattern scan (SPS) acquisition protocol may be a more accurate and sensitive baseline measure for the diagnosis and follow-up of papilledema than presently used methods, according to the results of a pilot study, said Mazen Y. Choulakian, MD.

Eight eyes from four newly diagnosed patients with papilledema secondary to idiopathic intracranial hypertension (IIH) were compared with 8 eyes from healthy controls using SD-OCT SPS and peripapillary total retinal thickness (PRT). PRT and PT were both evaluated with SD-OCT, and a macular cube acquisition protocol centered on the optic disc was used to evaluate PRT.

“Papillary thickness measured with SD-OCT SPS is significantly higher than PRT when compared [with] the control group,” said Dr. Choulakian, Ophthalmology, Centre Hospitalier Universitaire de Sherbrooke, QC, Canada. “We speculate that papillary thickness is a more sensitive sign to monitor disease progression and response to treatment than PRT since it represents more accurately the clinical evaluation of papilledema.”

The SPS protocol may allow for a more precise follow up of patients who are under treatment for IHH, may develop a recurrence, or have chronic papilledema and are at risk for hemorrhages.

“I think it could be a really innovative, interesting tool,” said Dr. Choulakian, adding that the SD-OCT SPS protocol would be practical in the clinic.

The findings from the small pilot study must be compared with other protocols. If the results are borne out, the new protocol may become widely adopted.

“I think OCT to papilledema will probably become what OCT is to macular edema today, a standard of care,” Dr. Choulakian concluded.

For more articles in this issue of Ophthalmology Times Conference Briefclick here.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
© 2025 MJH Life Sciences

All rights reserved.